Mid-term Outcome of Positron Emission Tomography/Computed Tomography-assisted Radiofrequency Ablation in Primary and Secondary Liver Tumours - A Single-centre Experience

Clinical Oncology

Volumn 20, Issue 3, 2008, Pages 234-240

  Kuehl, H ^a   Stattaus, J ^a   Hertel, S ^a   Hunold, P ^a   Kaiser, G ^a   Bockisch, A ^a   Forsting, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Colorectal liver metastases; HCC; local tumour progression; radiofrequency ablation

Indexed keywords

ALGAROBA; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; IOBITRIDOL; MANNITOL;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUS SEDATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 40649113658     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.11.011     Document Type: Article

References (32)

1. Scheele J., Stang R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 1 (1995) 59-71
2. Poston G.J. Radiofrequency ablation of colorectal liver metastases: where are we really going?. J Clin Oncol 23 7 (2005) 1342-1344
3. Hong S.N., Lee S.Y., Choi M.S., et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39 3 (2005) 247-252
4. Cho C.M., Tak W.Y., Kweon Y.O., et al. The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma. Korean J Hepatol 11 1 (2005) 59-71
5. Berber E., Pelley R., and Siperstein A.E. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23 7 (2005) 1358-1364
6. Oshowo A., Gillams A., Harrison E., Lees W.R., and Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90 (2003) 1240-1243
7. Curley S.A. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol 32 6 Suppl 9 (2005) S109-S111
8. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-825
9. Quaia E., D'Onofrio M., Palumbo A., Rossi S., Bruni S., and Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16 7 (2006) 1599-1609
10. Bipat S., van Leeuwen M.S., Comans E.F., et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 237 1 (2005) 123-131
11. Cohade C., Osman M., Leal J., and Wahl R.L. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44 11 (2003) 1797-1803
12. Selzner M., Hany T.F., Wildbrett P., McCormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 240 6 (2004) 1027-1034
13. Beyer T., Antoch G., Blodgett T., Freudenberg L.F., Akhurst T., and Mueller S. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 30 4 (2003) 588-596
14. Antoch G., Kuehl H., Kanja J., et al. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 230 3 (2004) 879-885
15. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235 3 (2005) 728-739
16. Delbeke D., Martin W.H., Sandler M.P., Chapman W.C., Wright Jr. J.K., and Pinson C.W. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133 5 (1998) 510-515
17. Abitabile P., Hartl U., Lange J., and Maurer C.A. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 33 1 (2007) 67-71
18. White R.R., Avital I., Sofocleous C.T., et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 11 3 (2007) 256-263
19. Machi J., Oishi A.J., Sumida K., et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12 4 (2006) 318-326
20. Hansler J., Frieser M., Tietz V., et al. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes. J Vasc Interv Radiol 18 3 (2007) 405-410
21. van Duijnhoven F.H., Jansen M.C., Junggeburt J.M., et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 13 5 (2006) 651-658
22. Choi D., Lim H.K., Rhim H., et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long term results and prognostic factors in a large single-institution series. Eur Radiol 17 3 (2007) 684-692
23. Bartolozzi C., Donati F., Cioni D., et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14 1 (2004) 14-20
24. Sahani D.V., Kalva S.P., Tanabe K.K., et al. Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology 232 3 (2004) 810-814
25. Wallace J.R., Christians K.K., Quiroz F.A., Foley W.D., Pitt H.A., and Quebbeman E.J. Ablation of liver metastasis: is preoperative imaging sufficiently accurate?. J Gastrointest Surg 5 1 (2001) 98-107
26. Rosa F., Meimarakis G., Stahl A., et al. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin 43 4 (2004) 135-140
27. Amthauer H., Denecke T., Hildebrandt B., et al. Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions. Nuklearmedizin 45 4 (2006) 177-184
28. Sutherland L.M., Williams J.A., Padbury R.T., Gotley D.C., Stokes B., and Maddern G.J. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 141 2 (2006) 181-190
29. Anderson G.S., Brinkmann F., Soulen M.C., Alavi A., and Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28 3 (2003) 192-197
30. Nikfarjam M., Muralidharan V., and Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 139 1 (2006) 73-81
31. von Breitenbuch P., Kohl G., Guba M., Geissler E., Jauch K.W., and Steinbauer M. Thermoablation of colorectal liver metastases promotes proliferation of residual intrahepatic neoplastic cells. Surgery 138 5 (2005) 882-887
32. Hildebrand P., Kleemann M., Roblick U.J., et al. Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients. Langenbecks Arch Surg 391 2 (2006) 118-123